Cargando…
Rapid cognitive decline in a patient with chronic lymphocytic leukaemia: a case report
BACKGROUND: The use of monoclonal antibodies in various settings has been linked to the development of progressive multifocal leukoencephalopathy (PML). Whilst this association is well-described with agents such as rituximab and natalizumab, the literature describing the occurrence of PML with ofatu...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055117/ https://www.ncbi.nlm.nih.gov/pubmed/32127027 http://dx.doi.org/10.1186/s13256-020-2360-9 |